Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tesch

Showing results (81-90 of 282) with videos related to

Pageof 29
Sort By:
Der Internist|October 27, 1998
[Therapy of Hodgkin's disease. Optimization over 4 study generations]V Diehl, J Wolf, R Walshe, et al.
Cancer Genetics and Cytogenetics|October 15, 1991
Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?C Fonatsch, D Haase, M Freund, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphomaO Manzke, S Titzer, H Tesch, et al.
Oncology|January 1, 1990
Analysis of immunoglobulin, T cell receptor and bcr rearrangements in human malignant lymphoma and Hodgkin's diseaseH Tesch, P May, G R Krueger, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1989
Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosisA Albus, M Saalmann, H Tesch, et al.
Leukemia|June 1, 1991
Over-expression of lck in Burkitt's lymphoma cell linesM Jücker, H Abts, D Eick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectivesJ Wolf, H Tesch, R Parsa-Parsi, et al.
Growth Regulation|June 1, 1993
Effects of insulin-like growth factor binding protein complexes on human fibroblast growthG H Tesch, H J Cornell, A C Herington, et al.
Leukemia Research|August 1, 1996
Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infectionS C Klein, D Kube, H Abts, et al.
European Journal of Immunology|February 1, 1984
Heterogeneous and monoclonal helper T cells induce similar anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibody populations in the primary adoptive response. I. Isotype distributionH Tesch, F I Smith, W J Müller-Hermes, et al.
Pageof 29

Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
Der Internist|October 27, 1998
[Therapy of Hodgkin's disease. Optimization over 4 study generations]V Diehl, J Wolf, R Walshe, et al.
Cancer Genetics and Cytogenetics|October 15, 1991
Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?C Fonatsch, D Haase, M Freund, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphomaO Manzke, S Titzer, H Tesch, et al.
Oncology|January 1, 1990
Analysis of immunoglobulin, T cell receptor and bcr rearrangements in human malignant lymphoma and Hodgkin's diseaseH Tesch, P May, G R Krueger, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1989
Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosisA Albus, M Saalmann, H Tesch, et al.
Leukemia|June 1, 1991
Over-expression of lck in Burkitt's lymphoma cell linesM Jücker, H Abts, D Eick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectivesJ Wolf, H Tesch, R Parsa-Parsi, et al.
Growth Regulation|June 1, 1993
Effects of insulin-like growth factor binding protein complexes on human fibroblast growthG H Tesch, H J Cornell, A C Herington, et al.
Leukemia Research|August 1, 1996
Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infectionS C Klein, D Kube, H Abts, et al.
European Journal of Immunology|February 1, 1984
Heterogeneous and monoclonal helper T cells induce similar anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibody populations in the primary adoptive response. I. Isotype distributionH Tesch, F I Smith, W J Müller-Hermes, et al.
Pageof 29